Lupinus angustifolius L.

Angustifoline, an alkaloid, can be isolated from Lupinus angustifolius L. alkaloid extract. Angustifoline exhibits antimicrobial activity. Angustifoline could have bacteriostatic effects against S. aureus, B. subtilis, E. coli, P. aeruginosa and B. thuringiensis.

3,4,5-Trimethoxyphenylacetic acid is a trimethoxylated phenylacetic acid derivative and also a major metabolite of 3,4,5-trimethoxyphenylethylamine. 3,4,5-Trimethoxyphenylacetic acid is produced from the oxidation of 3,4,5-trimethoxyphenylacetaldehyde catalyzed by mouse CYP2C29, and it also serves as a starting material for the synthesis of intermediates of methoxylated phenylacetamides. 3,4,5‑Trimethoxyphenylacetic acid exhibits no significant cataleptic activity and does not prolong pentobarbital-induced sleep duration. 3,4,5-Trimethoxyphenylacetic acid is used in metabolism-related studies.

Angustone B is a pyranoisoflavone compound and an antifeedant. Angustone B can be isolated from the roots of Lupinus albus and Lupinus angustifolius. Angustone B exhibits feeding inhibitory activity against larvae of Costelytra zealandica.

Angustone A (2'-Hydroxylupalbigenin) is a diisoprenylated isoflavone with insect feeding inhibitory activity and moderate antifungal activity. Angustone A can be converted into various phenolic metabolites by Aspergillus flavus through modification of the isoprenyl side chains at the C-6 and C-3' positions. Angustone A can be used in studies on antifungal properties of natural products, insect feeding behavior, fungal biotransformation, and anticancer activity.

3,4,5-Trimethoxyphenylacetic acid (Standard) is the analytical standard of 3,4,5-Trimethoxyphenylacetic acid (HY-W009713). This product is intended for research and analytical applications. 3,4,5-Trimethoxyphenylacetic acid is a trimethoxylated phenylacetic acid derivative and also a major metabolite of 3,4,5-trimethoxyphenylethylamine. 3,4,5-Trimethoxyphenylacetic acid is produced from the oxidation of 3,4,5-trimethoxyphenylacetaldehyde catalyzed by mouse CYP2C29, and it also serves as a starting material for the synthesis of intermediates of methoxylated phenylacetamides. 3,4,5‑Trimethoxyphenylacetic acid exhibits no significant cataleptic activity and does not prolong pentobarbital-induced sleep duration. 3,4,5-Trimethoxyphenylacetic acid is used in metabolism-related studies.